Actualités 17.04.2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 17.04.2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 14.02.2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 19.10.2023 Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment Biel-based Mimix Biotherapeutics announced the closure of a significant investment round, drawing participation from both European and Asian inve...
News 10.01.2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 04.12.2023 Bern University of Applied Sciences launches the Institute for Patient-Centered Digital Health The Bern University of Applied Sciences is set to enhance its foothold in medical informatics with the establishment of a new institute dedicated...
News 14.11.2023 Opening of the Dynamic Imaging Center at sitem-insel in Bern sitem-insel has inaugurated the Dynamic Imaging Center, a groundbreaking facility that introduces a novel approach to X-ray imaging.
News 16.10.2023 Adiposs completes the phase I clinical trial of its flagship product ImageBAT Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...
News 23.08.2023 Sion’s Pôle Santé takes shape with the laying of the first stone Valued at CHF 86 million, the Pôle Santé campus aims to be a platform for the exchange of knowledge, experience and opportunities in the healthca...
Actualités 09.03.2022 La start-up genevoise Agora Care commence ses tests cliniques Spécialisée dans le stockage d'images médicales centrées sur le patient, Agora Care lance trois projets pilotes cliniques dans la Health Valley.
News 23.11.2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
ニュース 10.02.2021 バイオポールがライフサイエンス特化の3施設を2024年までにオープン スイス・イノベーション・パーク・ネットワーク・ウエスト EPFLに属するバイオポールが、3棟の新施設建設で拡大を続けています。新施設はライフサイエンス分野に特化し、2024年までに関連企業の入居用に23万㎡のオフィススペースと研究施設が整備される予定です。
Actualités 15.12.2021 La Source lance la plateforme d’innovation collaborative H4 Avec H4, La Source ouvre la première plateforme d’innovation collaborative dédiée aux soins et à la santé dans le canton de Vaud.
Actualités 16.11.2021 Un hub dédié à l’innovation médicale à la Clinique de Genolier La clinique de Genolier et le groupe privé Swiss Medical Network ont posé la première pierre d'un nouveau pôle dédié à l'innovation médicale. Est...
Actualités 27.10.2021 ONWARD Medical entre en bourse et lève CHF 93 millions La spin-off de l'EPFL, ONWARD Medical, est entrée en bourse sur Euronext Bruxelles avec une cotation secondaire sur Euronext Amsterdam, portant l...
Actualités 12.10.2021 Le pionnier des neurothérapies MindMaze lève USD 125 millions MindMaze, pionnier mondial sur le marché de la neurothérapie numérique, a levé USD 125 millions auprès d'AlbaCore Capital Group. Cela porte la va...
News 19.06.2023 Revolutionary breakthrough in prostate cancer treatment at the University of Bern In an exciting turn of events in the world of cancer therapy, researchers from the University of Bern, Inselspital Bern, and the University of Co...